Cationic nanoparticles for delivery of amphotericin B: preparation, characterization and activity in vitro
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
26/08/2013
26/08/2013
01/05/2008
|
Resumo |
Abstract Background Particulate systems are well known to be able to deliver drugs with high efficiency and fewer adverse side effects, possibly by endocytosis of the drug carriers. On the other hand, cationic compounds and assemblies exhibit a general antimicrobial action. In this work, cationic nanoparticles built from drug, cationic lipid and polyelectrolytes are shown to be excellent and active carriers of amphotericin B against C. albicans. Results Assemblies of amphotericin B and cationic lipid at extreme drug to lipid molar ratios were wrapped by polyelectrolytes forming cationic nanoparticles of high colloid stability and fungicidal activity against Candida albicans. Experimental strategy involved dynamic light scattering for particle sizing, zeta-potential analysis, colloid stability, determination of AmB aggregation state by optical spectra and determination of activity against Candida albicans in vitro from cfu countings. Conclusion Novel and effective cationic particles delivered amphotericin B to C. albicans in vitro with optimal efficiency seldom achieved from drug, cationic lipid or cationic polyelectrolyte in separate. The multiple assembly of antibiotic, cationic lipid and cationic polyelctrolyte, consecutively nanostructured in each particle produced a strategical and effective attack against the fungus cells. This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and by the Fundação de Âmparo à Pesquisa do Estado de São Paulo. This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and by the Fundação de Âmparo à Pesquisa do Estado de São Paulo. |
Identificador |
1477-3155 http://www.producao.usp.br/handle/BDPI/33004 10.1186/1477-3155-6-6 |
Idioma(s) |
eng |
Relação |
Journal of Nanobiotechnology |
Direitos |
openAccess Vieira and Carmona-Ribeiro; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
Tipo |
article original article |